Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders

S Zhu, F Liu, R Zhang, Z Xiong, Q Zhang… - Frontiers in …, 2022 - frontiersin.org
In recent years, neurological diseases including Alzheimer's disease, Parkinson's disease
and stroke are one of the main causes of death in the world. At the same time, the incidence …

Neolignans in Magnolia officinalis as natural anti-Alzheimer's disease agents: A systematic review

N Li, Y Liang, L Zhang, C Xu, L Wang - Ageing Research Reviews, 2024 - Elsevier
Background Magnolia officinalis, a traditional herbal medicine widely used in clinical
practice, exerts antibacterial, anti-tumor, anti-inflammatory, antioxidant, and anti-aging …

Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint

M Faysal, J Khan, M Zehravi, N Nath, LP Singh… - Chinese medicine, 2023 - Springer
Honokiol is a neolignan biphenol found in aerial parts of the Magnolia plant species. The
Magnolia plant species traditionally belong to China and have been used for centuries to …

The neuropharmacological effects of magnolol and honokiol: a review of signal pathways and molecular mechanisms

X Dai, L Xie, K Liu, Y Liang, Y Cao, J Lu… - Current molecular …, 2023 - ingentaconnect.com
Magnolol and honokiol are natural lignans with good physiological effects. As the main
active substances derived from Magnolia officinalis, their pharmacological activities have …

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

I Husain, S Zameer, T Madaan, A Minhaj… - Metabolic brain …, 2019 - Springer
Today, neurological disorders such as epilepsy, depression, tardive dyskinesia, and stress,
and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease …

[HTML][HTML] Magnoflorine improves cognitive deficits and pathology of Alzheimer's disease via inhibiting of JNK signaling pathway

L Zhong, Y Qin, M Liu, J Sun, H Tang, Y Zeng, J Zhang… - Phytomedicine, 2023 - Elsevier
Background Cognitive deficit is the main clinical feature of Alzheimer's disease (AD), and the
massive death of neuronal cells is the leading cause of cognitive deficits. So, there is an …

[HTML][HTML] Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease

M Akagi, N Matsui, H Akae, N Hirashima… - Journal of …, 2015 - Elsevier
Developed regions, including Japan, have become “aged societies,” and the number of
adults with senile dementias, such as Alzheimer's disease (AD), Parkinson's disease, and …

Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells

EJ Yang, JY Lee, SH Park, T Lee, KS Song - Food and chemical toxicology, 2013 - Elsevier
In the course of screening for neuroprotective natural products, Magnoliae Cortex showed
potent inhibition of hippocampal neuronal HT22 cell death. Obovatol, honokiol, and …

Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells

DY Chuang, MH Chan, Y Zong, W Sheng, Y He… - Journal of …, 2013 - Springer
Background The bark of magnolia has been used in Oriental medicine to treat a variety of
remedies, including some neurological disorders. Magnolol (Mag) and honokiol (Hon) are …

A honokiol-enriched Magnolia officinalis Rehder & EH Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 …

V Borgonetti, P Governa, F Manetti… - Journal of Pharmacy …, 2021 - academic.oup.com
Objectives The exposure of neurons to an excessive excitatory stimulation induces the
alteration of the normal neuronal function. Mood disorders are among the first signs of …